Tofacitinib	drug	
CYP2D6	drug_target	
UGT1A1	drug_target	
SLCO2B1	drug_target	
Clopidogrel	drug	
PTK6	drug_target	
FLT4	drug_target	
JAK3	drug_target	
FMO1	drug_target	
ERBB2	drug_target	
TEK	drug_target	
MTOR	drug_target	
HCAR3	drug_target	
ALB	drug_target	
stage, non-small cell lung cancer	phenotype	
TAP1	drug_target	
FKBP1A	drug_target	
CYP2B6	drug_target	
SLC16A1	drug_target	
FCGR2B	drug_target	
CYP3A5	drug_target	
Interferon Gamma-1b	drug	
Osimertinib	drug	
FGFR3	drug_target	
Crizotinib	drug	
C1S	drug_target	
CYP19A1	drug_target	
ABCG2	drug_target	
SLC47A1	drug_target	
FGF2	drug_target	
PDGFRA	drug_target	
KDR	drug_target	
KIT	drug_target	
Interstitial lung and liver disease	phenotype	
IFNGR2	drug_target	
CYP1A2	drug_target	
ALK	drug_target	
Panitumumab	drug	
Trastuzumab Emtansine	drug	
NNMT	drug_target	
airway disease	phenotype	
MET	drug_target	
HCAR2	drug_target	
FCGR3A	drug_target	
Trastuzumab	drug	
ABCC1	drug_target	
ABCB1	drug_target	
P2RY12	drug_target	
Afatinib	drug	
C1R	drug_target	
SH2B3	drug_target	
FGF1	drug_target	
CES1	drug_target	
FMO3	drug_target	
Lapatinib	drug	
SLC16A3	drug_target	
C1QB	drug_target	
Niacin	drug	
ITK	drug_target	
Vandetanib	drug	
FCGR3B	drug_target	
CYP3A4	drug_target	
PDGFRB	drug_target	
CYP2C9	drug_target	
QPRT	drug_target	
SLC5A8	drug_target	
EGFR	drug_target	
C1QA	drug_target	
JAK1	drug_target	
ORM1	drug_target	
CYP2C8	drug_target	
FLT1	drug_target	
FCGR1A	drug_target	
FCGR2A	drug_target	
SLCO1B1	drug_target	
Pazopanib	drug	
JAK2	drug_target	
CYP2C19	drug_target	
C1QC	drug_target	
FCGR2C	drug_target	
Sirolimus	drug	
SLC22A5	drug_target	
IFNGR1	drug_target	
VEGFA	drug_target	
ERBB4	drug_target	
